The FDA is forming a work group to explore the possibility of allowing the short-term importation of some sole-source, medically necessary drugs when there are conditions that “create significant barriers to, and ultimately threaten, patient access,” Commissioner of Food and Drugs Dr. Scott Gottlieb announced July 19. The move is a radical — albeit limited — departure from th... Read More